Scientific Publications & Articles
Scientific Publications
2012
Jeschke U, Wiest I, Schumacher AL, Kupka M, Rack B, Stahn R, Karsten U, Mayr D, Friese K, Dian D.
Anticancer Res. 2012 May;32(5):2185-9.
PMID:22593508 [PubMed - indexed for MEDLINE]
2. Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults.
Ulsemer P, Toutounian K, Kressel G, Schmidt J, Karsten U, Hahn A, Goletz S.
Benef Microbes. 2012 Jun 1;3(2):99-111.
PMID:22417778 [PubMed - indexed for MEDLINE]
3. Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate.
Ulsemer P, Toutounian K, Schmidt J, Karsten U, Goletz S.
Appl Environ Microbiol. 2012 Jan;78(2):528-35. Epub 2011 Nov 18.
PMID:22101046 [PubMed - indexed for MEDLINE]
4. Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964.
Ulsemer P, Toutounian K, Schmidt J, Leuschner J, Karsten U, Goletz S.
Regul Toxicol Pharmacol. 2012 Mar;62(2):336-46. Epub 2011 Nov 6.
PMID:22085591 [PubMed - indexed for MEDLINE]
2010
Lin,W.-M., Karsten,U., Goletz,S., Cheng,R.-C., Cao,Y.: Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells. Virchows Arch. 456: 403-409 (2010).
Fan,X.-N., Karsten,U., Goletz,S., Cao,Y.: Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas. Pathol.Res.Pract. 206: 585-589 (2010).
Karsten,U., Butschak,G., Stahn,R., Goletz,S.: A novel series of anti-human glycophorin A (CD235a) antibodies defining five extra- and intracellular epitopes. Int.Immunopharmacol. 10: 1354-1360 (2010).
Lin,W.-M., Karsten,U., Goletz,S., Cheng,R.-C., Cao,Y.: Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells. Int.J.Exp.Path. (online, 2010).
2009
Jeschke,U., Walzel,H., Mylonas,I., Papadopoulos,P., Shabani,N., Kuhn,C., Schulze,S., Friese,K., Karsten,U., Anz,D., Kupka,M.S.: The human endometrium expresses the glycoprotein Mucin-1 and shows positive correlation for Thomsen-Friedenreich-epitope expression and galectin-1 binding. J.Histochem.Cytochem. (2009).
Jeschke,U., Mylonas,I., Kunert-Keil,C., Stahn,R., Scholz,C., Janni,W., Kuhn,C., Schröder,E., Mayr,D., Friese,K.: Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer. Histochem.Cell Biol. 131: 283-295 (2009).
Dian,D., Janni,W., Kuhn,C., Mayr,D., Karsten,U., Mylonas,I., Friese,K., Jeschke,U.: Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies. Onkologie 32: 238-244 (2009).
Christensen,P.A., Danielczyk,A., Ravn,P., Larsen,M., Stahn,R., Karsten,U., Goletz,S.: Modifying antibody specificity by chain shuffling of VH/VL between antibodies with related specificities. Scand.J.Immunol. 69: 1-10 (2009).
2008
Larsen,M., Jensen,K.B., Christensen,P.A., Suarez,E., Paris,D., Sanz,L., Ravn,P., Sauce,D., Saas,P., Goletz,S., Alvarez-Vallina,L., Kristensen,P.: Functionally fused antibodies – a novel adjuvant fusion system. J. Immunol.Methods 31: 220-227 (2008).
Cao,Y., Merling,A., Karsten,U., Goletz,S., Punzel,M., Kraft,R., Butschak,G., Schwartz-Albiez,R.: Expression of CD175 (Tn), CD175s (sialosyl-Tn), and CD176 (Thomsen-Friedenreich antigen) on malignant human hematopoietic cells. Int.J.Cancer 123: 89-99 (2008).
2007
Christensen,P.A., Danielczyk,A., Ravn,P., Stahn,R., Karsten,U., Goletz,S.: A monoclonal antibody to Lewis Y/Lewis b revealing mimicry of the histone H1 to carbohydrate structures. Scand.J.Immunol. 65: 362-367 (2007).
Ravn,P., Stahn,R., Danielczyk,A., Faulstich,D., Karsten,U., Goletz,S.: The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs. Cancer Immunol.Immunother. 56: 1345-1357 (2007).
2006
Butschak,G., Karsten,U., Schelhaas,U., Ott,H., Emmendörffer,A., Niemeyer,B., Helmholz,H., Goletz,S.: Detection, isolation and partial characterization of an immunostimulating glycoprotein from Rhodococcus fascians. Internat.Immunopharmacol. 6: 1441-1450 (2006).
Jeschke,U., Kuhn,C., Mylonas,I., Schulze,S., Friese,K., Mayr,D., Speer,R., Briese,V., Richter,D.-U., Haase,M., Karsten,U.: Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues. Histopathology 48: 394-406 (2006).
Danielczyk,A., Stahn,R., Faulstich,D., Löffler,A., Märten,A., Karsten,U., Goletz,S.: PankoMab: a potent new generation anti-tumour MUC1 antibody. Cancer Immunol.Immunother. 55: 1337-1347 (2006).
2005
Stahn,R., Goletz,S., Stahn,R., Wilmanowski,R., Wang,X., Briese,V., Friese,K., Jeschke,U.: Human chorionic gonadotropin (hCG) as inhibitor of E-selectin-mediated cell adhesion. Anticancer Res. 25: 1811-1816 (2005).
Karsten,U., von Mensdorff-Pouilly,S., Goletz,S.: What makes MUC1 a tumor antigen? Tumor Biol. 26: 217-220 (2005).
2004
Zeisig,R., Stahn,R., Wenzel,K., Behrens,D., Fichtner,I.: Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro.Biochim.Biophys.Acta 28: 31-40 (2004).
Ravn,P., Danielczyk,A., Jensen,K.B., Kristensen,P., Christensen,P.A., Larsen,M., Karsten,U., Goletz,S.: Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen. J.Mol.Biol. 343: 985-996 (2004).
Christensen,P.A., Danielczyk,A., Stahn,R., Goletz,S.: Simple separation of DNA in antibody purification. In: Protein Expression and Purification 37: 468-471 (2004).
Karsten,U., Serttas,N., Paulsen,H., Danielczyk,A., Goletz,S.: Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1). Glycobiology 14: 681-692 (2004).
2003
Jeschke,U., Wang,X., Briese,V., Friese,K., Stahn,R.: Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion. Histochem.Cell Biol. 119: 345-354 (2003).
Goletz,S., Cao,Y., Danielczyk,A., Ravn,P., Schöber,U., Karsten,U.: Thomsen-Friedenreich antigen: the “hidden” tumour antigen. Adv.Exp.Med.Biol., Vol.535, Glycobiology and Medicine (ed. Axford,J.S.), Kluwer Academic/Plenum Publishers, New York, pp.147-162 (2003).
2002
Goletz,S., Christensen,P.A., Kristensen,P., Blohm,D., Tomlinson,I., Winter,G., Karsten,U.: Selection of large diversities of antiidiotypic antibody fragments by phage display. J.Mol.Biol. 315: 1087-1097 (2002).
Karsten,U.: CD175 Workshop Panel report. In: Leucocyte Typing VII, ed. Mason,D., et al., Oxford University Press, Oxford, p. 201-202 (2002).
Karsten,U.: CD176 Workshop Panel report. In: Leucocyte Typing VII, ed. Mason,D., et al., Oxford University Press, Oxford, p. 202-203 (2002).
Cao,Y., Karsten,U., Schwartz-Albiez,R.: Expression of Thomsen-Friedenreich-related carbohydrate antigens on human leukaemia cells. In: Leucocyte Typing VII, ed. Mason,D., et al., Oxford University Press, Oxford, p. 204-205 (2002).
Butschak,G., Karsten,U.: Isolation and characterization of Thomsen-Friedenreich-specific antibodies from human serum. Tumor Biol. 23: 113-122 (2002).
Other Articles
2010
Baumeister H, Goletz S.: A Matter of Cell Line Development. In: European BioPharmaceutical Review 2010: Apr. Download
2009
Baumeister H, Goletz S.: Novel Glycosylation Technologies for the Development of Biosimilars and Biobetters. In: Innovations In Pharmaceutical Technology 2009: Dec. Download
2005
Baumeister H, Goletz S.: GlycoExpress: A novel expression system for the optimal glycosylation of biotherapeutics. In: Speciality Chemicals Magazine 2005: Vol 25.
Baumeister H, Schoeber U, Schlangstedt M, Stahn R, Goletz S.: A novel human expression system for generating glycoprotein with higher activity, fully human glycosylation, and optimised sialylation. In: BioProcessing Journal 2005: Vol 4. Download
Baumeister H, Goletz S.: Voll funktionsfähige humane dendritische Zelllinie. In: Laborwelt 2005: Vol 6. Download
2004
Goletz S, Baumeister H.: Opportunities with NEMOD & GLYCOTOPE. In: R&D FOCUS drugnews 2004: Vol 13.
Baumeister H.: GlycoEngineering – a Technology for Production of Glycoproteins. In: BioTOPics 2004: Vol 24. Download
Baumeister H, Goletz S.. A novel technology for the production of highly active therapeutic proteins. In: DrugPlus international 2004: Vol 03. Download

